Prostatis Group’s Travelers Companies TRV Stock Holding History

Prostatis Group’s Portfolio TRV Stock Details TRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Sell	1,004 -50	-5%	-$14.6K	0.08%	144
2025 Q4	$306K	Sell	1,054 -3,577	-77%	-$1.01M	0.07%	134
2025 Q3	$1.29M	Buy	4,631 +606	+15%	+$162K	0.32%	66
2025 Q2	$1.08M	Sell	4,025 -319	-7%	-$84.1K	0.31%	67
2025 Q1	$1.15M	Sell	4,344 -934	-18%	-$233K	0.36%	61
2024 Q4	$1.27M	Sell	5,278 -55	-1%	-$13.7K	0.37%	63
2024 Q3	$1.25M	Buy	5,333 +503	+10%	+$111K	0.41%	60
2024 Q2	$999K	Buy	4,830 +234	+5%	+$50.3K	0.35%	66
2024 Q1	$1.06M	Buy	4,596 +676	+17%	+$144K	0.4%	59
2023 Q4	$747K	Buy	3,920 +7	+0.2%	+$1.21K	0.31%	73
2023 Q3	$629K	Sell	3,913 -688,711	-99%	-$115M	0.31%	61
2023 Q2	$735K	Buy	692,624 +688,174	+15,465%	+$121M	0.34%	62
2023 Q1	$764K	Sell	4,450 -26	-0.6%	-$4.73K	0.4%	57
2022 Q4	$839K	Buy	+4,476	New	+$805K	0.51%	46

Other funds holding TRV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prostatis Group's TRV Position: Q1 2026 in Review

Prostatis Group reduced its Travelers Companies (TRV) stake by 4.7% in Q1 2026, selling an estimated $14.6K and leaving 1,004 shares worth $293K. The position accounts for 0.08% of the portfolio, ranked #144.

Prostatis Group first reported a position in TRV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.29M in Q3 2025. 1,785 funds tracked by Wall St. Rank hold TRV as of Q1 2026.

Prostatis Group held 1,004 shares of Travelers Companies worth $293K as of Q1 2026.
Prostatis Group sold 50 Travelers Companies shares in Q1 2026, an estimated $14.6K.
Travelers Companies made up 0.08% of Prostatis Group's portfolio in Q1 2026, its #144 holding.
Prostatis Group first reported a position in Travelers Companies in Q4 2022 and has held it in 14 quarters since.
Prostatis Group's Travelers Companies position peaked at $1.29M in Q3 2025.
1,785 funds tracked by Wall St. Rank held Travelers Companies as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.